
|Articles|December 2, 2016
Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/rheumatoid-arthritis-biosimilar-development-highli" target="_blank">View the story "Rheumatoid Arthritis Biosimilar Development Highlights Week in Specialty Pharmacy" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Reimagining Pharmacy: A Call to Action for Pharmacy Professionals
2
FDA Approves Milestone Oral Therapy for Adults With Thalassemia Anemia
3
Experimental Multistage Malaria Vaccine Demonstrates Promising Protection in Early Trial
4
FDA Approves Narsoplimab-wuug for Transplant-Associated Thrombotic Microangiopathy
5










































































































































































































